Assessing tumor growth and distribution in a model of prostate cancer metastasis using bioluminescence imaging

Clinical and Experimental Metastasis

Volumn 22, Issue 8, 2005, Pages 674-684

  Drake, Justin M ^a   Gabriel, Curtis L ^a   Henry, Michael D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Bioluminescence imaging; Intracardiac injection; Metastasis; Prostate cancer; Xenograft

Indexed keywords

ACCURACY; ADRENAL METASTASIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BIOLUMINESCENCE; BIOLUMINESCENCE IMAGING; BONE METASTASIS; CANCER CELL CULTURE; CANCER MODEL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMAGING SYSTEM; LIVER METASTASIS; MALE; METASTASIS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; PERIOSTEUM TRANSPLANTATION; PREDICTION; PROSTATE CANCER; QUANTITATIVE ANALYSIS; SCID MOUSE; SIGNAL DETECTION; TUMOR GROWTH;

ANIMALS; CELL DIVISION; LUMINESCENCE; MALE; MICE; MICE, SCID; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS; X-RAYS;

EID: 33747483777     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-006-9011-4     Document Type: Article

References (51)

1. Jemal A, Murray T, Ward E et al (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10-30
2. Scher HI (2003) Prostate carcinoma: defining therapeutic objectives and improving overall outcomes. Cancer 97:758-771
3. Bubendorf L, Schopfer A, Wagner U et al (2000) Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 31:578-583
4. Shah RB, Mehra R, Chinnaiyan AM et al (2004) Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program. Cancer Res 64:9209-9216
5. Rubin MA, Putzi M, Mucci N et al (2000) Rapid ("warm") autopsy study for procurement of metastatic prostate cancer. Clin Cancer Res 6:1038-1045
6. Roudier MP, True LD, Higano CS et al (2003) Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone. Hum Pathol 34:646-653
7. Tantivejkul K, Kalikin LM, Pienta KJ (2004) Dynamic process of prostate cancer metastasis to bone. J Cell Biochem 91:706-717
8. Edlund M, Sung SY, Chung LW (2004) Modulation of prostate cancer growth in bone microenvironments. J Cell Biochem 91:686-705
9. Roy-Burman P, Wu H, Powell WC et al (2004) Genetically defined mouse models that mimic natural aspects of human prostate cancer development. Endocr Relat Cancer 11:225-254
10. Winter SF, Cooper AB, Greenberg NM (2003) Models of metastatic prostate cancer: a transgenic perspective. Prostate Cancer Prostatic Dis 6:204-211
11. Singh AS, Figg WD (2005) In vivo models of prostate cancer metastasis to bone. J Urol 174:820-826
12. Stephenson RA (1992) Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J Natl Cancer Inst 84:951-957
13. Fu X, Herrera H, Hoffman RM (1992) Orthotopic growth and metastasis of human prostate carcinoma in nude mice after transplantation of histologically intact tissue. Int J Cancer 52:987-990
14. Gingrich JR, Barrios RJ, Morton RA et al (1996) Metastatic prostate cancer in a transgenic mouse. Cancer Res 56:4096-4102
15. Wang S, Gao J, Lei Q et al (2003) Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4:209-221
16. Nemeth JA, Harb JF, Barroso U Jr et al (1999) Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Cancer Res 59:1987-1993
17. Corey E, Quinn JE, Bladou F et al (2002) Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells. Prostate 52:20-33
18. Lee Y, Schwarz E, Davies M et al (2003) Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone. J Orthop Res 21:62-72
19. Wu T, Sikes RA, Cui Q et al (1998) Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-presenting tumors in athymic and scid/bg mice using LNCaP and lineage-derived metastatic sublines. Int J Cancer 77:887-894
20. Henry MD, Silva MD, Wen S et al (2005) Spiculated periosteal response induced by intraosseous injection of 22Rv1 prostate cancer cells resembles subset of bone metastases in prostate cancer patients. Prostate 65:347-354
21. Blomme EA, Dougherty KM, Pienta KJ et al (1999) Skeletal metastasis of prostate adenocarcinoma in rats: morphometric analysis and role of parathyroid hormone-related protein. Prostate 39:187-197
22. Keller ET, Brown J (2004) Prostate cancer bone metastases promote both osteolytic and osteoblastic activity. J Cell Biochem 91:718-729
23. Schneider A, Kalikin LM, Mattos AC et al (2005) Bone turnover mediates preferential localization of prostate cancer in the skeleton. Endocrinology 146:1727-1736
24. Chishima T, Miyagi Y, Wang X et al (1997) Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. Cancer Res 57:2042-2047
25. Contag CH, Spilman SD, Contag PR et al (1997) Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 66:523-531
26. Choy G, O'Connor S, Diehn FE et al (2003) Comparison of non-invasive fluorescent and bioluminescent small animal optical imaging. Biotechniques 35:1022-1026, 1028-1030
27. Ray P, De A, Min JJ et al (2004) Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res 64:1323-1330
28. Troy T, Jekic-McMullen D, Sambucetti L et al (2004) Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models. Mol Imaging 3:9-23
29. Kalikin LM, Schneider A, Thakur MA et al (2003) In vivo visualization of metastatic prostate cancer and quantitation of disease progression in immunocompromised mice. Cancer Biol Ther 2:656-660
30. Rosol TJ, Tannehill-Gregg SH, LeRoy BE et al (2003) Animal models of bone metastasis. Cancer 97:748-757
31. Scatena CD, Hepner MA, Oei YA et al (2004) Imaging of bioluminescent LNCaP-luc-M6 tumors: a new animal model for the study of metastatic human prostate cancer. Prostate 59:292-303
32. Jenkins DE, Yu SF, Hornig YS et al (2003) In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3M-luc-C6 cells in murine models of human prostate cancer. Clin Exp Metastasis 20:745-756
33. Rehemtulla A, Stegman LD, Cardozo SJ et al (2000) Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2:491-495
34. Jenkins DE, Oei Y, Hornig YS et al (2003) Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin Exp Metastasis 20:733-744
35. Sramkoski RM, Pretlow TG 2nd, Giaconia JM et al (1999) A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell Dev Biol Anim 35:403-409
36. Arguello F, Baggs RB, Frantz CN (1988) A murine model of experimental metastasis to bone and bone marrow. Cancer Res 48:6876-6881
37. Lehr JE, Pienta KJ (1998) Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. J Natl Cancer Inst 90:118-123
38. Simpson MA, Reiland J, Burger SR et al (2001) Hyaluronan synthase elevation in metastatic prostate carcinoma cells correlates with hyaluronan surface retention, a prerequisite for rapid adhesion to bone marrow endothelial cells. J Biol Chem 276:17949-17957
39. Dimitroff CJ, Lechpammer M, Long-Woodward D et al (2004) Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin. Cancer Res 64:5261-5269
40. Glinsky VV, Glinsky GV, Rittenhouse-Olson K et al (2001) The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. Cancer Res 61:4851-4857
41. Paget S (1889) The distribution of secondary growths in cancer of the breast. Lancet 1:99-101
42. Batson OV (1995) The function of the vertebral veins and their role in the spread of metastases. 1940. Clin Orthop Relat Res 312:4-9
43. Angelucci A, Gravina GL, Rucci N et al (2004) Evaluation of metastatic potential in prostate carcinoma: an in vivo model. Int J Oncol 25:1713-1720
44. Pettaway CA, Pathak S, Greene G et al (1996) Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res 2:1627-1636
45. Byers HR, Etoh T, Lee KW et al (1993) Organ-specific metastases in immunodeficient mice injected with human melanoma cells: a quantitative pathological analysis. Melanoma Res 3:247-253
46. Fodstad O, Kjonniksen I, Aamdal S et al (1988) Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells. Cancer Res 48:4382-4388
47. Chirgwin JM, Mohammad KS, Guise TA (2004) Tumor-bone cellular interactions in skeletal metastases. J Musculoskelet Neuronal Interact 4:308-318
48. Bloom RA, Libson E, Husband JE et al (1987) The periosteal sunburst reaction to bone metastases. A literature review and report of 20 additional cases. Skeletal Radiol 16:629-634
49. Hove B, Gyldensted C (1990) Spiculated vertebral metastases from prostatic carcinoma. Report of first two cases. Neuroradiology 32:337-339
50. Lehrer HZ, Maxfield WS, Nice CM (1970) The periosteal "sunburst" pattern in metastatic bone tumors. Am J Roentgenol Radium Ther Nucl Med 108:154-161
51. Wyche LD, de Santos LA (1978) Spiculated periosteal reaction in metastatic disease resembling osteosarcoma. Orthopedics 1:215-221